Interleukin 17 role as a biomarker in Systemic Lupus Erythematosus patients.

Interleukin-26 in Systemic Lupus Erythematosus: Demographic Correlates, Mechanistic Insights, and the Impact of Rituximab Therapy

Serum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.

Interleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity

Clinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients

Interferon-Induced Protein-10 and Plasma Interleukin-26 in Systemic Lupus Erythematosus

Inflammatory markers and fever in SLE patients

Study of Interleukin-17 and Fc Gamma Receptor in SLE Patients and Its Relation to Disease Activity and Clinical Presentation

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Interleukin-4, and interferon-gamma roles as biomarkers in Systemic Lupus Erythematosus patients.